Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 05 Mar 2026 for LeonaBio, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark Worthington: trading record in brief
Mark Worthington (board member) discloses dealings in LeonaBio, Inc. to SEC (Form 4). We count 21 filings; the first trade dates from 18 May 2022 and the latest from 4 March 2026.
Sales make up the whole of the open-market record (8 sales, €39k). Other entries cover 9 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
On 5 March 2026 came the latest disclosure, an open-market sale for €6,141 in LeonaBio, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Worthington
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,726 shares0Common StockSEC:0001861464-26-000004:0
3,667 shares0Common StockSEC:0001861464-26-000002:0
36,666 shares0Common StockSEC:0001415889-25-019066:0
3,651 shares@ US$0.553.2% of flowCommon StockSEC:0001415889-25-000525:0
7,767 shares@ US$2.4129.2% of flowCommon StockSEC:0001415889-24-004151:0
7,767 shares@ US$2.4129.2% of flowCommon StockSEC:0001209191-24-001145:0
3,396 shares@ US$7.06100.0% of flowCommon StockSEC:0001209191-22-039344:0
7 of 7 declarations
